Status:
TERMINATED
Hair-sparing Whole Brain Radiotherapy
Lead Sponsor:
University Hospital, Ghent
Conditions:
Brain Metastases
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Up to 10% of patients with cancer will develop symptomatic brain metastases. Given this limited survival it is important to consider quality of life (QOL) when treating these patients. Whole brain rad...
Eligibility Criteria
Inclusion
- Brain metastases
- Age ≥ 18 years.
- Signed informed consent
- Recursive Partitioning Analysis (RPA) class III patients
- Recursive Partitioning Analysis (RPA) class I-II patients and \>3 brain metastases
- Patients with small cell lung cancer extended disease eligible for prophylactic Whole-Brain Radiotherapy (WBRT).
Exclusion
- Previous whole brain radiotherapy
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT01421316
Start Date
January 1 2013
End Date
October 1 2014
Last Update
June 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital, Belgium
Ghent, Belgium